No profile data available.
Amgen Inc. (AMGN) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Thousand Oaks, United States, with about 31,500 full-time employees.
It reported revenue of $36.75 billion for fiscal year 2025, up 10.0% from fiscal year 2024, and net income of $7.71 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $10.05 billion, up 9.5% from a year before. United States was its largest region in fiscal year 2025, with 72% of revenue. Its market capitalization was $224.29 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
Amgen reported $36.75 billion in revenue for fiscal year 2025, up 10.0% from $33.42 billion in fiscal year 2024. In Q2 2026 revenue was $10.05 billion.
United States: 72% of revenue by region in fiscal year 2025, followed by Rest of The World (28%).
$224.29 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include AbbVie Inc. (ABBV), Novartis AG (NVS), AstraZeneca PLC (AZN), Pfizer Inc. (PFE).